Patents by Inventor Andre Zimmermann

Andre Zimmermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
    Patent number: 8846670
    Abstract: The invention relates to compounds of the formula: or their racemic, enantiomeric or diastereoisomeric isomers, or pharmaceutically acceptable salts of the compounds of formula I or the racemic, enantiomeric or diasteroisomeric isomers.
    Type: Grant
    Filed: July 1, 2010
    Date of Patent: September 30, 2014
    Assignee: Sanofi
    Inventors: Eric Bacque, Maurice Brollo, Annie Clauss, Youssef El Ahmad, Bruno Filoche-Romme, Frank Halley, Karl Andreas Karlsson, Gilbert Marciniak, Baptiste Ronan, Laurent Schio, Bertrand Vivet, Fabrice Viviani, Andre Zimmermann
  • 2,3-dihydro-1H-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof
    Patent number: 8828997
    Abstract: The invention relates to a product of formula (I) where R1, R2, R3, and R4 are as defined herein, the therapeutic use of the product, a process to make the product, and a pharmaceutical composition comprising the product.
    Type: Grant
    Filed: July 1, 2010
    Date of Patent: September 9, 2014
    Assignee: Sanofi
    Inventors: Maurice Brollo, Annie Clauss, Youssef El Ahmad, Bruno Filoche-Romme, Frank Halley, Karl Andreas Karlsson, Gilbert Marciniak, Baptiste Ronan, Laurent Schio, Bertrand Vivet, Fabrice Viviani, Andre Zimmermann
  • NOVEL 1,2,3,4-TETRAHYDRO-PYRIMIDO(1,2-A)PYRIMIDIN-6-ONE DERIVATIVES, PREPARATION THEREOF, AND PHARMACEUTICAL USE THEREOF
    Publication number: 20120208810
    Abstract: The invention relates to the novel materials of formula (I), where: R1 is an optionally substituted L-aryl or L-heteroaryl, such that L is a single bond, alkyl, CO, or CO-alk, or L-X, with L? being an alkyl and X being O or S; R2 is H or alkyl; R3 is an alkyl optionally substituted by Hal; and R4 is Hou Hal, wherein said materials are in any isomeric form and the salts thereof, to be used as drugs.
    Type: Application
    Filed: July 1, 2010
    Publication date: August 16, 2012
    Applicant: SANOFI
    Inventors: Eric Bacque, Maurice Brollo, Annie Clauss, Youssef El Ahmad, Bruno Filoche-Romme, Frank Halley, Karl Andreas Karlsson, Gilbert Marciniak, Baptiste Ronan, Laurent Schio, Bertrand Vivet, Fabrice Viviani, Andre Zimmermann
  • PLASTIC MOLDING MATERIAL AND METHOD FOR PRODUCING IT
    Publication number: 20120153532
    Abstract: A plastic molding material contains at least one filler and a polymer resin, selected from the group made up of cyanate ester resins, epoxy novolac resins, multifunctional epoxy resins, bismaleimide resins and their mixtures. The proportion of filler in the plastic molding material is in the range of 65 to 92 wt. %, with reference to the overall mass of the plastic molding material.
    Type: Application
    Filed: April 6, 2010
    Publication date: June 21, 2012
    Inventors: Irene Jennrich, Andre Zimmermann, Frieder Sundermeier
  • NOVEL 2,3-DIHYDRO-1H-IMIDAZO(1,2-A)PYRIMIDIN-5-ONE DERIVATIVES, PREPARATION THEREOF, AND PHARMACEUTICAL USE THEREOF
    Publication number: 20120142679
    Abstract: The invention relates to the novel materials of formula (I), where R1 is an optionally substituted L-aryl or -heteroaryl, such that L is: an alkyl or CO, or LX, with Lbeing an alkyl and X being O or S; R2 is H or an alkyl; R3 is an alkyl optionally substituted by Hal; and R4 is Hou Hal, wherein said materials are in any isomeric form and the salts thereof, to be used as drugs.
    Type: Application
    Filed: July 1, 2010
    Publication date: June 7, 2012
    Applicant: SANOFI
    Inventors: Maurice Brolio, Annie Clauss, Youssef El Ahmad, Bruno Filoche-Romme, Frank Halley, Karl Andreas Karlsson, Gilbert Marciniak, Baptiste Ronan, Laurent Schio, Bertrand Vivet, Fabrice Viviani, Andre Zimmermann
  • Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors
    Patent number: 7482342
    Abstract: Compound corresponding to general formula (I): in which, R1 represents a hydrogen or halogen atom, an NH2, NHR2, NHCOR2, NO2, CN, CH2NH2 and CH2NHR2; or alternatively R1 represents an optionally substituted phenyl or an optionally substituted heteroaromatic group; Ar represents an optionally substituted phenyl group or an optionally substituted heteroaromatic group; n represents 0, 1, 2 or 3; in the form of a base, of an addition salt with an acid, of a hydrate or of a solvate. Application in therapy.
    Type: Grant
    Filed: April 1, 2005
    Date of Patent: January 27, 2009
    Assignee: sanofi-aventis
    Inventors: Hugues D'Orchymont, Luc Van Hijfte, Andre Zimmermann
  • INDAZOLECARBOXAMIDE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF MALARIA
    Publication number: 20070185187
    Abstract: The invention relates to methods of treating or preventing malaria which comprises administering to a patient in need thereof, an effective amount of a 1H-indazole-3-carboxamide derivative of general formula (I), in the form of a base or of an addition salt with an acid, or in the form of a hydrate or of a solvate of said base or acid addition salt.
    Type: Application
    Filed: September 13, 2006
    Publication date: August 9, 2007
    Applicant: SANOFI-AVENTIS
    Inventors: Hugues D'ORCHYMONT, Laurent FRAISSE, Andre ZIMMERMANN
  • Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors
    Publication number: 20060004000
    Abstract: Compound corresponding to general formula (I): in which, R1 represents a hydrogen or halogen atom, an NH2, NHR2, NHCOR2, NO2, CN, CH2NH2 and CH2NHR2; or alternatively R1 represents an optionally substituted phenyl or an optionally substituted heteroaromatic group; Ar represents an optionally substituted phenyl group or an optionally substituted heteroaromatic group; n represents 0, 1, 2 or 3; in the form of a base, of an addition salt with an acid, of a hydrate or of a solvate. Application in therapy.
    Type: Application
    Filed: April 1, 2005
    Publication date: January 5, 2006
    Applicant: SANOFI-AVENTIS
    Inventors: Hugues D'Orchymont, Luc Van Hijfte, Andre Zimmermann